Cardiac Contractility Modultion Therapy: A Review

Author(s): Mary K. Kowal, MSN, APRN, AGNP-C

Contact Hours 1.00

CERP A 1.00

Expires Dec 01, 2029

Topics: Cardiovascular

Population: Adult, Geriatric

Role: APRN, Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Before you Begin

1. Reflect on the following question: What new knowledge or perspective do you hope to gain from this activity?

2. Review: Implicit Bias and its Impact on Patient Outcomes (License requirement for California)

Description

Cardiac contractility modulation (CCM) therapy is an emerging device-based treatment for select patients with heart failure who remain symptomatic despite guideline-directed medical therapy. By targeting myocardial function through a unique mechanism, CCM represents an important addition to the evolving landscape of heart failure management. This comprehensive review examines the physiologic basis of CCM, patient selection considerations, clinical outcomes, implications for practice, and ongoing and future directions for research and implementation.

Objectives

  • Describe the indication for cardiac contractility modulation therapy and the patient specific factors that can effect therapy response
  • Describe the mechanisms of action of cardiac contractility modulation
  • Identify implications for care of patients with an implantable impulse generator receiving CCM therapy

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.